BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 13627583)

  • 1. [The inhibitory activity of serum against T2r + bacteriophage in relation to properdin].
    FRANCQ JC; EYQUEM A; GUYOTJEANNIN N
    Ann Inst Pasteur (Paris); 1959 Feb; 96(2):178-83. PubMed ID: 13627583
    [No Abstract]   [Full Text] [Related]  

  • 2. [Properdin in the course of chronic inflammatory rheumatism; comparative study by hemolysis inhibition & neutralization of bacteriophage T2r+].
    EYQUEM A; FRANCQ JC; GUYOT-JEANNIN N; JACQUELINE F
    Ann Inst Pasteur (Paris); 1958 Dec; 95(6):748-53. PubMed ID: 13617714
    [No Abstract]   [Full Text] [Related]  

  • 3. [Observations on the determination of properdin by means of bacteriophage neutralization].
    PERNIS B; TURRI M
    Boll Ist Sieroter Milan; 1958; 37(9-10):414-24. PubMed ID: 13607654
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation of the serum properdin levels in neoplastic diseases determined by the bacteriophage neutralization assay.
    SEKIGUCHI M; ASHIKAWA K; MOTOYA K; ISHIBASHI Y
    Gan; 1962 Jun; 53():129-43. PubMed ID: 13910377
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of properdin in the first days of life. Study by bacteriophage neutralization].
    CONCA G
    Minerva Pediatr; 1959 Sep; 11():992-6. PubMed ID: 13811458
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDIES ON HOST DEFENSES AGAINST CANCER. 1. ON THE BACTERIOPHAGE NEUTRALIZING ACTIVITY OF SERUMS].
    SEKIGUCHI M
    Arerugi; 1963; 12():348-57. PubMed ID: 14095328
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
    BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
    J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the inactivation of phage by the properdin system. II. Quantitative assay of phage-neutralizing activity.
    BARLOW JL; VAN VUNAKIS H; LEVINE L
    J Immunol; 1958 May; 80(5):349-55. PubMed ID: 13539379
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antibacteriophage power of the blood considered as an index of properdin activity in patients of pulmonary tuberculosis].
    BASILICO F; RIMOLDI R; GRASSI F
    G Ital Tuberc Mal Torace; 1961; 15():5-6. PubMed ID: 13687595
    [No Abstract]   [Full Text] [Related]  

  • 11. Interference by endotoxic polysaccharides with inactivation of coliphage by human serum.
    LANDY M; TRAPANI RJ; SHEAR MJ
    Br J Exp Pathol; 1958 Dec; 39(6):618-30. PubMed ID: 13607920
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the phage-neutralizing activity of the properdin system in the blood of cancer patients treated with conventional radiotherapy, Clinico-experimental research].
    PAOLINI FA
    Minerva Med; 1961 Apr; 52():1346-52. PubMed ID: 13732561
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of the inactivation of phage by the properdin system. I. Evidence for complement, properdin and magnesium requirements.
    BARLOW JL; VAN VUNAKIS H; LEVINE L
    J Immunol; 1958 May; 80(5):339-48. PubMed ID: 13539378
    [No Abstract]   [Full Text] [Related]  

  • 14. Interpretation of properdin levels determined by phage neutralization technique.
    COWAN KM
    Science; 1958 Oct; 128(3327):778-9. PubMed ID: 13592254
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental contribution to the problem of inactivation of bacteriophages by the properdin system].
    HUSMANN KH
    Z Hyg Infektionskr; 1959; 146():89-96. PubMed ID: 14405590
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of the phage-neutralizing property in the blood of newborn infants and of mothers of the properdin system as a method of evaluating the latter.
    CARLETTI B
    Minerva Pediatr; 1959 Jun; 11(25-26):706-7. PubMed ID: 13674297
    [No Abstract]   [Full Text] [Related]  

  • 17. Streptococcal pyrogenic exotoxin B cleaves properdin and inhibits complement-mediated opsonophagocytosis.
    Tsao N; Tsai WH; Lin YS; Chuang WJ; Wang CH; Kuo CF
    Biochem Biophys Res Commun; 2006 Jan; 339(3):779-84. PubMed ID: 16329996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esterified whey proteins can protect Lactococcus lactis against bacteriophage infection. Comparison with the effect of native basic proteins and L-polylysines.
    Sitohy M; Chobert JM; Haertlé T
    J Agric Food Chem; 2005 May; 53(9):3727-34. PubMed ID: 15853427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the chemical inhibition of T2r+ bacteriophage.
    BOURKE AR; ROBBINS ML; SMITH PK
    J Immunol; 1952 Jul; 69(1):75-88. PubMed ID: 14946403
    [No Abstract]   [Full Text] [Related]  

  • 20. Chromatographic purification of T2r bacteriophage.
    TAUSSIG A; CREASER EH
    Biochim Biophys Acta; 1957 May; 24(2):448-9. PubMed ID: 13436462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.